Literature DB >> 17024453

The 20-min trial of the maintenance of wakefulness test is profoundly affected by motivation.

Roni Shreter1, Ron Peled, Giora Pillar.   

Abstract

Assessment of the ability to maintain wakefulness, although very important both for research and for clinical purposes, is still equivocal. The current gold standard is considered the Maintenance of Wakefulness Test (MWT), although there are two different potential protocols to perform it and the normal reference range has been determined on selected populations. The effect of potential "penalty" on failing the test (i.e., presenting sleepiness) has not been seriously studied. We therefore planned this study to examine the effect of motivation on the MWT results in a potentially sleepy population. We hypothesized that with the knowledge that participants may lose their driving license if they fail the test, the results would indicate significantly less sleepiness than reported for other populations. Fifty-four consecutive subjects at high risk of sleepiness referred to the sleep laboratory for evaluation of their ability to maintain wakefulness were studied. All were referred by the National Council for Driving Safety, knowing that if they failed the test, their driving license would not be renewed. Referral reasons were previously diagnosed: obstructive sleep apnea (OSA; 43%), sleep-related accident (7%), or other causes to suspect sleepiness. All underwent a full-night polysomnography (PSG) followed by MWT, five trials of 20 min each (MWT20). Of the 54 participants, 13 were treated for OSA and 28 had untreated OSA, 21 of them had severe OSA (Respiratory Disturbance Index > 30/h). Seventy-four percent of the participants had a BMI >30 kg/m2. Only 5 of the participants fell asleep in any of the MWT trials (one to five trials), which could not be predicted by severity of OSA, age, BMI, or variables derived from the previous night PSG. Of the 21 patients with severe untreated OSA, only 1 patient fell asleep during the MWT20. We conclude that motivation profoundly affects the MWT results, raising the question what should be considered normal or abnormal when sleepy results may cause penalty or other practical implications. In addition, we believe that these results suggest that for renewal of driving license purposes, the MWT20 is insufficient. We speculate that MWT40, with tighter cutoff threshold, would be a more effective tool.

Entities:  

Mesh:

Year:  2006        PMID: 17024453     DOI: 10.1007/s11325-006-0072-z

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  38 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

Review 2.  A normative study of the maintenance of wakefulness test (MWT).

Authors:  K Doghramji; M M Mitler; R B Sangal; C Shapiro; S Taylor; J Walsleben; C Belisle; M K Erman; R Hayduk; R Hosn; E B O'Malley; J M Sangal; S L Schutte; J M Youakim
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1997-11

Review 3.  Catastrophes, sleep, and public policy: consensus report.

Authors:  M M Mitler; M A Carskadon; C A Czeisler; W C Dement; D F Dinges; R C Graeber
Journal:  Sleep       Date:  1988-02       Impact factor: 5.849

4.  The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander.

Authors:  J Terán-Santos; A Jiménez-Gómez; J Cordero-Guevara
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

5.  Sleepiness-related accidents in sleep apnea patients.

Authors:  S Horstmann; C W Hess; C Bassetti; M Gugger; J Mathis
Journal:  Sleep       Date:  2000-05-01       Impact factor: 5.849

6.  Disorders of excessive sleepiness. Treatment improves ability to stay awake but does not reduce sleepiness.

Authors:  R B Sangal; L Thomas; M M Mitler
Journal:  Chest       Date:  1992-09       Impact factor: 9.410

7.  Fits and other causes of loss of consciousness while driving.

Authors:  M Parsons
Journal:  Q J Med       Date:  1986-03

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Does arousal frequency predict daytime function?

Authors:  R N Kingshott; H M Engleman; I J Deary; N J Douglas
Journal:  Eur Respir J       Date:  1998-12       Impact factor: 16.671

10.  Does uvulopalatopharyngoplasty inhibit automobile accidents?

Authors:  P O Haraldsson; C Carenfelt; M Lysdahl; C Tingvall
Journal:  Laryngoscope       Date:  1995-06       Impact factor: 3.325

View more
  5 in total

1.  Measuring the ability to stay awake: role of motivation.

Authors:  James A Rowley
Journal:  Sleep Breath       Date:  2006-12       Impact factor: 2.816

2.  Forty- versus 20-minute trials of the maintenance of wakefulness test regimen for licensing of drivers.

Authors:  Limor Arzi; Roni Shreter; Baruch El-Ad; Ron Peled; Giora Pillar
Journal:  J Clin Sleep Med       Date:  2009-02-15       Impact factor: 4.062

3.  The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA.

Authors:  Nick A Antic; Peter Catcheside; Catherine Buchan; Michael Hensley; Matthew T Naughton; Sharn Rowland; Bernadette Williamson; Samantha Windler; R Doug McEvoy
Journal:  Sleep       Date:  2011-01-01       Impact factor: 5.849

4.  Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class.

Authors:  Donald L Bliwise; Lynn Marie Trotti; Anthony G Wilson; Sophia A Greer; Cathy Wood-Siverio; Jorge J Juncos; Stewart A Factor; Alan Freeman; David B Rye
Journal:  Mov Disord       Date:  2012-07-02       Impact factor: 10.338

5.  Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.

Authors:  Sarah Ronnebaum; Morgan Bron; Dipen Patel; Diane Menno; Shay Bujanover; David Kratochvil; Eleanor Lucas; Carl Stepnowsky
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.